P61.2 Anemia of prematurity

Name of the Condition

• Anemia of Prematurity
  
  • Other terms: Prematurity-related anemia, Neonatal anemia of prematurity

Summary

Anemia of prematurity is a common condition in preterm infants characterized by a lower than normal red blood cell count or hemoglobin level. This occurs due to the combination of shortened red blood cell lifespan, insufficient erythropoietin production, and rapid growth in premature newborns.

Causes

The condition arises from multiple factors, including the shortened lifespan of fetal red blood cells, reduced erythropoietin production in preterm infants, and increased blood loss from frequent laboratory testing. Additionally, preterm infants have lower iron stores and may experience dilutional anemia from rapid postnatal growth.

Risk Factors

• Premature birth (especially very low birth weight or extremely preterm infants)
• Low gestational age at birth
• Frequent blood sampling for laboratory tests
• Inadequate iron stores at birth
• Intrauterine growth restriction

Symptoms

• Pallor (pale skin or mucous membranes)
• Tachycardia (rapid heart rate)
• Tachypnea (rapid breathing)
• Poor feeding or lethargy
• Irritability or fussiness
• In severe cases, signs of heart failure or shock

Diagnosis

Diagnosis is confirmed through a complete blood count (CBC) to measure hemoglobin and hematocrit levels. Additional tests may include reticulocyte count, serum iron studies, and erythropoietin levels to assess the underlying cause and guide management.

Treatment Options

• Monitoring hemoglobin levels and clinical status is often sufficient in mild cases.
• Red blood cell transfusions may be administered for symptomatic anemia or when hemoglobin falls below a certain threshold.
• Iron supplementation (oral or intravenous) may be used to support red blood cell production.
• Erythropoietin therapy is sometimes considered to stimulate red blood cell production, though its use is variable.

Prognosis and Follow-Up

The prognosis is generally good with appropriate management, as anemia of prematurity typically resolves as the infant matures and erythropoietin production increases. Follow-up involves regular monitoring of hemoglobin levels and clinical signs until the infant is stable and growing well.

Complications

• Delayed growth or development if anemia is severe or prolonged
• Increased risk of apnea (pauses in breathing)
• Exacerbation of other neonatal conditions, such as respiratory distress
• Potential need for multiple blood transfusions, which carry risks like infection or transfusion reactions

Lifestyle & Prevention

• Minimizing blood loss through careful sampling techniques (e.g., using smaller volumes or point-of-care testing) can help reduce the risk.
• Ensuring adequate nutrition, including iron and other nutrients, supports red blood cell production.
• Early recognition and management of anemia can prevent complications.

When to Seek Professional Help

• Seek immediate medical attention if the infant shows signs of severe anemia, such as extreme pallor, lethargy, or respiratory distress.
• Consult a healthcare provider if the infant’s feeding, activity level, or growth is affected by suspected anemia.

Tips for Medical Coders

• Code P61.2 is used for anemia of prematurity, a condition specific to preterm infants. Documentation should clearly indicate the infant’s gestational age, hemoglobin levels, and any interventions (e.g., transfusions or erythropoietin therapy) to support accurate coding. Ensure the diagnosis aligns with clinical findings and laboratory results.